Bremer Trust National Association’s AbbVie ABBV Stock Holding History

Bremer Trust National Association’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$1.8M	Buy	19,500 +7,446	+62%	+$655K	0.39%	70
2018 Q3	$1.14M	Sell	12,054 -2,337	-16%	-$222K	0.29%	109
2018 Q2	$1.33M	Sell	14,391 -4,019	-22%	-$393K	0.37%	83
2018 Q1	$1.74M	Sell	18,410 -611	-3%	-$67.1K	0.5%	58
2017 Q4	$1.84M	Buy	19,021 +499	+3%	+$47K	0.49%	60
2017 Q3	$1.65M	Buy	18,522 +6,373	+52%	+$485K	0.46%	70
2017 Q2	$881K	Sell	12,149 -1,063	-8%	-$71.5K	0.25%	100
2017 Q1	$861K	Sell	13,212 -16	-0.1%	-$1.01K	0.23%	100
2016 Q4	$828K	Sell	13,228 -2,478	-16%	-$151K	0.23%	108
2016 Q3	$990K	Buy	15,706 +1,209	+8%	+$78.3K	0.27%	103
2016 Q2	$898K	Buy	14,497 +2,097	+17%	+$128K	0.25%	96
2016 Q1	$708K	Buy	12,400 +6,315	+104%	+$352K	0.2%	109
2015 Q4	$360K	Sell	6,085 -1,438	-19%	-$82.8K	0.11%	160
2015 Q3	$410K	Sell	7,523 -1,029	-12%	-$67K	0.13%	143
2015 Q2	$574K	Sell	8,552 -820	-9%	-$53.5K	0.17%	128
2015 Q1	$549K	Sell	9,372 -658	-7%	-$39.8K	0.17%	122
2014 Q4	$657K	Sell	10,030 -287	-3%	-$18.1K	0.21%	111
2014 Q3	$596K	Buy	10,317 +15	+0.1%	+$833	0.2%	110
2014 Q2	$581K	Sell	10,302 -2,341	-19%	-$123K	0.2%	114
2014 Q1	$649K	Sell	12,643 -145	-1%	-$7.33K	0.24%	100
2013 Q4	$676K	Sell	12,788 -63	-0.5%	-$3.1K	0.26%	96
2013 Q3	$575K	Buy	12,851 +205	+2%	+$9.09K	0.24%	101
2013 Q2	$523K	Buy	+12,646	New	+$553K	0.23%	97

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bremer Trust National Association's ABBV Position: Q4 2018 in Review

Bremer Trust National Association increased its AbbVie (ABBV) stake by 62% in Q4 2018, buying an estimated $655K and bringing the position to 19,500 shares worth $1.8M. The position accounts for 0.39% of the portfolio, ranked #70.

Bremer Trust National Association first reported a position in ABBV in Q2 2013 and has held it in 23 quarters since. The position peaked at $1.84M in Q4 2017. 2,063 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

Bremer Trust National Association held 19,500 shares of AbbVie worth $1.8M as of Q4 2018.
Bremer Trust National Association bought 7,446 AbbVie shares in Q4 2018, an estimated $655K.
AbbVie made up 0.39% of Bremer Trust National Association's portfolio in Q4 2018, its #70 holding.
Bremer Trust National Association first reported a position in AbbVie in Q2 2013 and has held it in 23 quarters since.
Bremer Trust National Association's AbbVie position peaked at $1.84M in Q4 2017.
2,063 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on Bremer Trust National Association's 13F filing for Q4 2018, filed 11 Feb 2019.